Novartis Third-Quarter Net Rises on Lucentis, Exforge
Novartis AG indicated Alcon Inc. shareholders should take another look at its $11.5 billion buyout offer now that an increase in the Swiss drugmakers share price and a rally in the franc have lifted the value of the bid. Novartis, which owns 77 perce...